載入...
Expression profile of CADM1 and CADM4 in triple negative breast cancer with primary systemic therapy
Triple negative breast cancer (TNBC) is defined by a lack of ER, PgR, and HER2 expression, and to date there have been no significant advances in treatment by targeted therapies against those molecules. Therefore, primary systemic therapy (PST) followed by surgery is the standard therapy for patient...
Na minha lista:
| 發表在: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313031/ https://ncbi.nlm.nih.gov/pubmed/30655848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9727 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|